BioSpace News Archive

Clinical collaboration marks an important milestone in partnership with Exelixis to further develop cabozantinib

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced that it plans to release its second quarter 2020 financial results on Tuesday, July 28, 2020.

Citigroup Global Markets Inc., in its capacity as Joint Global Coordinator, notifies that the stabilization period relating to Calliditas Therapeutics AB ‘s American Depositary Shares, traded on The Nasdaq Global Select Market has ended and no further stabilization transactions will be effected.

Investments in innovative medical devices follow the fund’s initial closing in May 2019

Citryll announced it closed a total fundraise of € 18.5 million, led by Seventure, co-led by BioGeneration Ventures with existing investors BOM Brabant Ventures, BrightGene and ModiQuest contributing to this round.

Painless & simple day-care procedure makes Bees-Haus technique suitable for global reach

Hansa grants Sarepta exclusive license to develop and promote imlifidase as a potential pre-treatment prior to the administration of gene therapy in Duchenne muscular dystrophy and Limb-girdle muscular dystrophy, for patients with neutralizing antibodies to adeno-associated virus

Continuous, Active Air Purifier Uses NASA-inspired ActivePure Technology

EUSA Pharma announced that the U.S. Food & Drug Administration has approved a randomized, double-blind, placebo-controlled Phase 3 clinical trial protocol to evaluate the safety and efficacy of intravenous siltuximab plus standard of care in hospitalized patients with COVID-19 associated Acute Respiratory Distress Syndrome.

Textile innovator HeiQ’s antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled.